[Polyamine and middle-molecule peptide levels in patients with chronic myeloid leukemia during treatment].
Proliferative activity of myeloblasts as well as the content of possible regulators of hemopoiesis--polyamines and medium-molecular peptides were investigated in the time course of chronic myeloid leukemia. It has been noted that their levels correlate with the leukemic process progressing, and with the response to the chemotherapy conducted.
Shardakov
V I
VI
Dem'ianova
V T
VT
Pankov
V N
VN
Sitnikov
S A
SA
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D010455:Peptides / Q000378:metabolism*; D010956:Plasmapheresis; D011073:Polyamines / Q000378:metabolism*; D011700:Putrescine / Q000378:metabolism; D013095:Spermidine / Q000378:metabolism; D013096:Spermine / Q000378:metabolism
D000970:Antineoplastic Agents; D010455:Peptides; D011073:Polyamines; D013096:Spermine; D013095:Spermidine; D011700:Putrescine
Soderzhanie poliaminov i srednemolekuliarnykh peptidov u bol'nykh khronicheskim mieloleĭkozom v protsesse lecheniia.